Back to funds
View filing
Euclidean Capital LLC
hedge fundUpdated 27 days agoManaged by Euclidean Capital Llc • Latest filing Q2 2026
Portfolio value
$439.8M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
13489.4%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $114M |
| Q2 2023 | $389.1M |
| Q3 2023 | $458.1M |
| Q4 2023 | $888.5M |
| Q1 2024 | $780M |
| Q2 2024 | $795.8M |
| Q3 2024 | $906.8M |
| Q4 2024 | $736.7M |
| Q1 2025 | $266.1M |
| Q2 2025 | $305.7M |
| Q3 2025 | $238M |
| Q4 2025 | $369.5M |
| Q1 2026 | $392.3M |
| Q2 2026 | $439.8M |
Top holdings
11 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | V VGES VANGUARD INTL EQUITY INDEX F | $271.6M | 3.24M | 61.76% | — |
| 2 | V VGES VANGUARD INDEX FDS | $113.3M | 520.0K | 25.77% | — |
| 3 | E ETHA ISHARES TR | $18.3M | 369.6K | 4.15% | — |
| 4 | O ORIC ORIC PHARMACEUTICALS INC | $10.7M | 989.4K | 2.44% | — |
| 5 | T TMSWW TEAMSHARES INC | $9M | 1.10M | 2.06% | — |
| 6 | F FHTX FOGHORN THERAPEUTICS INC | $7.7M | 1.57M | 1.75% | — |
| 7 | P PPLC PMV PHARMACEUTICALS INC | $3.5M | 2.63M | 0.80% | — |
| 8 | A ALEC ALECTOR INC | $2.6M | 1.31M | 0.60% | — |
| 9 | ? N/A SURROZEN INC | $2.3M | 87.7K | 0.52% | — |
| 10 | ? N/A TENAYA THERAPEUTICS INC | $751K | 1.02M | 0.17% | — |
| 11 | S SRZNW SURROZEN INC | $3K | 170.8K | 0.00% | — |